Your Daily Newt: Legalize It

As a service to our readers, every day we are delivering a classic moment from the political life of Newt Gingrich—until he either clinches the nomination or bows out.

Newt Gingrich occasionally smoked marijuana as a graduate student at Tulane. As he explained later, “that was a sign we were alive and in graduate school in that era.” Hey, it was the ’60s. So it made a certain amount of sense that as a back-bench congressman, he penned a letter to the editor of the Journal of the American Medical Association calling for the drug to be legalized for medicinal purposes:

We believe licensed physicians are competent to employ marijuana, and patients have a right to obtain marijuana legally, under medical supervision, from a regulated source. The medical prohibition does not prevent seriously ill patients from employing marijuana; it simply deprives them of medical supervision and denies them access to a regulated medical substance. Physicians are often forced to choose between their ethical responsibilities to the patient and their legal liabilities to federal bureaucrats.

Fast-forward to the present:

FACT:

Mother Jones was founded as a nonprofit in 1976 because we knew corporations and the wealthy wouldn't fund the type of hard-hitting journalism we set out to do.

Today, reader support makes up about two-thirds of our budget, allows us to dig deep on stories that matter, and lets us keep our reporting free for everyone. If you value what you get from Mother Jones, please join us with a tax-deductible donation today so we can keep on doing the type of journalism 2019 demands.

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate

We have a new comment system! We are now using Coral, from Vox Media, for comments on all new articles. We'd love your feedback.